Claus Cursiefen

22PUBLICATIONS
44CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Optical technologyInnate immunityTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 09, 2026
VEGF-A Antisense Oligonucleotide Therapy Inhibits Corneal Neovascularisation and Enhances Graft Survival in Murine High-Risk Corneal Transplantation.

|May 16, 2026
Living tissues and dead objects in the eye: The first description of ocular immune privilege by J.C. van Dooremaal in Albrecht Von Graefe's Archiv für Ophthalmologie in 1873.

|May 16, 2026
Early postoperative corneal thickness and 12-month endothelial cell outcomes after descemet membrane endothelial keratoplasty: A multicentre analysis.

|May 12, 2026
Corneal transplantation: Restoring sight to the blind.

|Jan 09, 2026
Limbal Epithelial Stem Cells in Review: Immune and Lymphangiogenic Privilege and Their Clinical Relevance.

Berbang Meshko, Thomas Volatier, Claus Cursiefen

|Jan 07, 2026
Higher-Order Aberrations, Corneal Density, and Visual Acuity After Excimer Laser Phototherapeutic Keratectomy (PTK) for Epithelial Basement Membrane Dystrophy.

Simon Helm, Johanna Wiedemann, Benjamin Rosswinkel

Pageof 4

Frequent Collaborators

7 joint publications

Thomas Volatier

4 joint publications

Berbang Meshko

3 joint publications

Johanna Wiedemann

3 joint publications

Björn Bachmann